About Proteinase-activated receptor 1
Proteinase-activated receptor 1 (F2R) is a protein
from Homo sapiens identified by UniProt accession
P25116, 425 residues long.
MolForge cross-references it against 0 known binders and
376 disease associations.
Target properties
| Protein name | Proteinase-activated receptor 1 |
| UniProt accession | P25116 |
| Gene | F2R |
| Organism | Homo sapiens |
| Length | 425 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Approved drugs hitting this target (1)
DrugCentral-linked approved drugs that act on this protein.
Disease associations (376)
Diseases linked to this target (Open Targets).
- myocardial infarction · score 0.57
- peripheral arterial disease · score 0.55
- neurodegenerative disease · score 0.49
- stroke · score 0.46
- serum albumin measurement · score 0.42
- coronary artery disease · score 0.41
- reticulocyte count · score 0.38
- Recurrent thrombophlebitis · score 0.37
- mean corpuscular hemoglobin · score 0.36
- mean platelet volume · score 0.36
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P25116-F1 | alphafold | PREDICTED | 74.59 | — |
Amino-acid sequence (425 residues)
MGPRRLLLVA ACFSLCGPLL SARTRARRPE SKATNATLDP RSFLLRNPND KYEPFWEDEE KNESGLTEYR LVSINKSSPL QKQLPAFISE DASGYLTSSW LTLFVPSVYT GVFVVSLPLN IMAIVVFILK MKVKKPAVVY MLHLATADVL FVSVLPFKIS YYFSGSDWQF GSELCRFVTA AFYCNMYASI LLMTVISIDR FLAVVYPMQS LSWRTLGRAS FTCLAIWALA IAGVVPLLLK EQTIQVPGLN ITTCHDVLNE TLLEGYYAYY FSAFSAVFFF VPLIISTVCY VSIIRCLSSS AVANRSKKSR ALFLSAAVFC IFIICFGPTN VLLIAHYSFL SHTSTTEAAY FAYLLCVCVS SISCCIDPLI YYYASSECQR YVYSILCCKE SSDPSSYNSS GQLMASKMDT CSSNLNNSIY KKLLT
Explore Proteinase-activated receptor 1 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets